• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种雾化一氧化氮加合物作为急性肺动脉高压的选择性肺血管扩张剂。

Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension.

作者信息

Lam Chen F, van Heerden Peter V, Ilett Kenneth F, Caterina Paul, Filion Pierre

机构信息

Department of Pharmacology, University of Western Australia, Crawley, Australia.

出版信息

Chest. 2003 Mar;123(3):869-74. doi: 10.1378/chest.123.3.869.

DOI:10.1378/chest.123.3.869
PMID:12628890
Abstract

STUDY OBJECTIVES

To determine the selective vasodilatory effects of two inhaled "NONOate" aerosols in a closed chest pig model of acute pulmonary hypertension (APH).

METHODS

APH was induced by IV infusion of the prostaglandin H(2)/thromboxane A(2) receptor agonist (U46619). Aerosolized diethylenetriamine nitric oxide (NO) adduct (DETA/NO, n = 4), dipropylenetriamine NO adduct (DPTA/NO, n = 4) [60 micro mol each], or placebo (n = 4) was delivered via the trachea. Hemodynamic parameters and blood samples were measured before and after inhalation therapy.

RESULTS

Compared to control animals, pulmonary vascular resistance and pulmonary arterial pressure were significantly reduced from 10 to 105 min after DETA/NO administration and from 10 to 45 min after DPTA/NO aerosol administration (p < 0.05). Both aerosols had no significant effect on systemic vascular resistance or systemic BP. Serum nitrite significantly increased after the inhalation of both NONOates (p < 0.01). There was a tendency for reduced intrapulmonary shunting, particularly after treatment with DETA/NO.

CONCLUSION

Both DETA/NO and DPTA/NO administered as aerosols selectively reduced pulmonary hypertension induced by U46619.

摘要

研究目的

在急性肺动脉高压(APH)的闭胸猪模型中,确定两种吸入性“NONOate”气雾剂的选择性血管舒张作用。

方法

通过静脉输注前列腺素H(2)/血栓素A(2)受体激动剂(U46619)诱导APH。经气管给予雾化的二乙三胺一氧化氮(NO)加合物(DETA/NO,n = 4)、二丙三胺NO加合物(DPTA/NO,n = 4)[各60微摩尔]或安慰剂(n = 4)。在吸入治疗前后测量血流动力学参数和采集血样。

结果

与对照动物相比,给予DETA/NO后10至105分钟以及给予DPTA/NO气雾剂后10至45分钟,肺血管阻力和肺动脉压显著降低(p < 0.05)。两种气雾剂对全身血管阻力或全身血压均无显著影响。吸入两种NONOate后血清亚硝酸盐显著增加(p < 0.01)。肺内分流有减少的趋势,尤其是在DETA/NO治疗后。

结论

作为气雾剂给药的DETA/NO和DPTA/NO均选择性降低了由U46619诱导的肺动脉高压。

相似文献

1
Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension.两种雾化一氧化氮加合物作为急性肺动脉高压的选择性肺血管扩张剂。
Chest. 2003 Mar;123(3):869-74. doi: 10.1378/chest.123.3.869.
2
Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury.雾化吸入可溶性一氧化氮供体可改善急性肺损伤患者的氧合及肺动脉高压。
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1536-42. doi: 10.1164/ajrccm.158.5.9802114.
3
The selective pulmonary vasodilatory effect of inhaled DETA/NO, a novel nitric oxide donor, in ARDS-a pilot human trial.新型一氧化氮供体吸入式DETA/NO在急性呼吸窘迫综合征中的选择性肺血管舒张作用——一项人体初步试验
J Crit Care. 2004 Mar;19(1):48-53. doi: 10.1016/j.jcrc.2004.02.009.
4
The effects of inhalation of a novel nitric oxide donor, DETA/NO, in a patient with severe hypoxaemia due to acute respiratory distress syndrome.新型一氧化氮供体DETA/NO吸入对一名因急性呼吸窘迫综合征导致严重低氧血症患者的影响。
Anaesth Intensive Care. 2002 Aug;30(4):472-6. doi: 10.1177/0310057X0203000413.
5
Soluble nitric oxide donor and surfactant improve oxygenation and pulmonary hypertension in porcine lung injury.
Nitric Oxide. 2000 Aug;4(4):412-22. doi: 10.1006/niox.2000.0292.
6
Effects of a nebulized NONOate, DPTA/NO, on group B streptococcus-induced pulmonary hypertension in newborn piglets.雾化吸入非诺多泮(DPTA/NO)对新生仔猪B族链球菌诱导的肺动脉高压的影响。
Pediatr Res. 2005 Mar;57(3):378-83. doi: 10.1203/01.PDR.0000150802.35283.27. Epub 2004 Dec 7.
7
Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension.雾化吸入西地那非对患有急性肺动脉高压的羔羊是一种选择性肺血管扩张剂。
Crit Care Med. 2001 May;29(5):1000-5. doi: 10.1097/00003246-200105000-00024.
8
Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension.
Crit Care Med. 1998 Aug;26(8):1390-6. doi: 10.1097/00003246-199808000-00026.
9
Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators.吸入式二氮烯二醇盐(硝普盐)作为选择性肺血管扩张剂。
Expert Opin Investig Drugs. 2002 Jul;11(7):897-909. doi: 10.1517/13543784.11.7.897.
10
Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.吸入一氧化氮与吸入雾化前列环素在评估肺血管阻力升高的心脏移植候选者中的比较。
Chest. 1998 Sep;114(3):780-6. doi: 10.1378/chest.114.3.780.

引用本文的文献

1
Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.一氧化氮(NO)供体脂质体气雾剂作为长效替代品用于治疗肺动脉高压,替代超短效吸入性一氧化氮。
Pharm Res. 2016 Jul;33(7):1696-710. doi: 10.1007/s11095-016-1911-7. Epub 2016 Apr 5.